Want to see AU:SHG full AI Analyst Report?
Singular Health Group Ltd (SHG) AI Stock Analysis
Singular Health Group Ltd
(ASX:SHG)
Weak financial performance from persistent losses and cash burn is the dominant factor, with neutral technical indicators and unattractive valuation from negative earnings providing little additional support.
Singular Health Group Ltd (SHG) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 58.70M
- Dividend Yield
- ―
- Average Volume (3M)
- 256.93K
- Price to Earnings (P/E)
- -8.9
- Beta (1Y)
- 0.92
- Revenue Growth
- 603.32%
- EPS Growth
- 10.57%
- Country
- Australia
- Employees
- 8
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Healthcare Information Services
Singular Health Group Ltd Business Overview & Revenue Model
Company Description
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anat...
Singular Health Group Ltd Financial Statement Overview
Summary
Revenue growth is positive but deeply negative margins, high cash burn, and low income/cash flow scores limit results; strengthened balance sheet with minimal debt offers partial support.
Income Statement
24NegativeBalance Sheet
67PositiveCash Flow
19Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.43M | 1.43M | 557.61K | 934.07K | 28.12K | 54.03K |
| Gross Profit | -4.06M | -4.02M | -86.22K | 516.36K | -3.58M | -2.11M |
| EBITDA | -6.67M | -6.69M | -6.27M | -2.58M | -4.52M | -5.65M |
| Net Income | -6.34M | -6.34M | -6.38M | -4.92M | -5.39M | -5.99M |
Balance Sheet | ||||||
| Total Assets | 11.24M | 11.24M | 14.21M | 2.35M | 3.00M | 2.14M |
| Cash, Cash Equivalents and Short-Term Investments | 10.06M | 10.06M | 13.68M | 1.45M | 691.51K | 1.14M |
| Total Debt | 109.96K | 109.96K | 0 | 218.45K | 2.51M | 85.66K |
| Total Liabilities | 699.20K | 699.20K | 1.11M | 909.59K | 2.94M | 391.50K |
| Stockholders Equity | 10.54M | 10.54M | 13.10M | 1.44M | 61.89K | 1.75M |
Cash Flow | ||||||
| Free Cash Flow | -5.45M | -5.45M | -2.37M | -2.51M | -2.49M | -2.92M |
| Operating Cash Flow | -5.30M | -5.30M | -2.34M | -2.44M | -2.46M | -2.91M |
| Investing Cash Flow | 5.37M | 5.37M | 88.14K | -3,559 | -635.21K | -17.12K |
| Financing Cash Flow | 1.67M | 1.67M | 14.48M | 3.21M | 2.65M | -69.25K |
Singular Health Group Ltd Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SHG, the sentiment is Positive. The current price of 0.18 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.18, and below the 200-day MA of 0.21, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 56.11 is Neutral, neither overbought nor oversold. The STOCH value of 91.53 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:SHG.
Singular Health Group Ltd Peers Comparison
Overall Rating
AU:RHT69Neutral
AU:ALC63Neutral
AU:M7T49Neutral- AU:SHG47Neutral
AU:BMT45Neutral
AU:AYA40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:RHT | 69Neutral | AUD 35.31M | 23.13 | 13.72% | ― | 42.25% | ― |
| AU:ALC | 63Neutral | AUD 148.48M | 64.70 | 2.53% | ― | 26.61% | 41.67% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| AU:M7T | 49Neutral | AUD 61.10M | -6.84 | -24.29% | ― | -17.35% | -47.29% |
| AU:SHG | 47Neutral | AUD 58.70M | -8.87 | -57.06% | ― | 603.32% | 10.57% |
| AU:BMT | 45Neutral | AUD 21.26M | -1.14 | -58.13% | ― | 2.08% | -195.31% |
| AU:AYA | 40Underperform | AUD 453.27M | -15.92 | -30.04% | ― | <0.01% | 2.08% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:SHG | Singular Health Group Ltd | 0.18 | -0.09 | -33.82% | |
| AU:M7T | Mach7 Technologies Ltd. | 0.26 | -0.04 | -13.33% | |
| AU:RHT | Resonance Health Ltd | 0.07 | 0.02 | 51.02% | |
| AU:BMT | Beamtree Holdings Ltd | 0.07 | -0.15 | -67.27% | |
| AU:AYA | Artrya Limited | 2.77 | -0.55 | -16.57% | |
| AU:ALC | Alcidion Group Limited | 0.11 | 0.02 | 22.22% |
Singular Health Group Ltd Corporate Events
Singular Health sets date and access details for 2026 AGM
Singular Health Group has announced that its 2026 Annual General Meeting will be held in person at Automic Group’s offices in Perth on 26 November 2026 at 11:00am AWST, with the Notice of Meeting and Explanatory Memorandum available online via...
Singular Health to Brief Investors on U.S. Imaging Repository Progress
Singular Health Group Ltd will host an online investor webinar on 8 October 2026, led by managing director Denning Chong and chief operating officer Dr Martina Mariano, to brief shareholders and investors on the company’s operations. Management...
Singular Health Sets November Date for 2026 AGM and Opens Director Nominations
Singular Health Group Ltd has issued advance notice that its 2026 Annual General Meeting is expected to be held around Thursday 26 November 2026, with full meeting details and resolutions to be circulated in a formal Notice of Meeting and Explanatory...
Singular Health Secures Florida Medicaid Imaging Repository Deal With FIU
Singular Health Group has signed an amended memorandum of understanding with Florida International University to design, deliver and operate a secure medical imaging data repository for Florida’s Medicaid program using its 3DICOM platform. The...
Singular Health Lodges ASX Corporate Governance Statement and Appendix 4G
Singular Health Group Ltd, an ASX-listed entity, has detailed its governance framework for the year ended 30 June 2026, including a board charter, appointment processes for directors and senior executives, and the company secretary’s direct acc...
Singular Health boosts revenue and expands globally despite ongoing losses
Singular Health Group Limited reported a sharp increase in revenues from ordinary activities to $1.43 million for the year ended 30 June 2026, up 507% from the prior year, while its loss after tax narrowed slightly to $6.34 million. Net tangible asse...
Singular Health Group Seeks ASX Quotation for 1.8 Million New Shares
Singular Health Group Ltd has applied for quotation on the ASX of 1,818,182 ordinary fully paid shares, with an issue date of 17 August 2026. The new share quotation expands the company’s listed equity base, potentially enhancing liquidity for...
Singular Health builds U.S. imaging footprint with PNS expansion, Florida pilots and Miami-Dade rollout
Singular Health Group reported a quarter of commercial and operational momentum, highlighting deeper engagement with U.S. healthcare payers and education providers as it builds out scalable imaging infrastructure solutions. The company ended the June...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 14, 2026